Promoter methylation of GSTP1 is absent in normal epithelium and present in 6.4% of proliferative inflammatory atrophy, in 70% of high-grade prostatic intraepithelial neoplasia and in 90% of prostate cancer [27]. Here, GSTP1 is linked to prostate carcinoma.